|
|
 |
|
ACOR: Acorda Therapeutics Inc - Stock News |
Enter Ticker:
|
|
| Nov 24, 2009 |
Acorda Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference |
| Nov 17, 2009 |
BiomedReports: News and FDA Updates for Acorda (Nasdaq:ACOR), Agilent (NYSE:A), ArQule (Nasdaq:ARQL) |
| Nov 16, 2009 |
Acorda Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference |
| Nov 06, 2009 |
Acorda Therapeutics (ACOR) |
| Nov 03, 2009 |
BUYINS.NET: Acorda Therapeutics (ACOR) Down After BUYINS.NET Report Predicted Weakness After Earnings |
| Nov 03, 2009 |
Acorda Therapeutics Reports Third Quarter 2009 Financial Results |
| Nov 03, 2009 |
Conference Calls Today: 8-8:45 A.M. EDT |
| Oct 27, 2009 |
Acorda Therapeutics to Host Conference Call to Report Third Quarter 2009 Financial Results on November 3, 2009 |
| Oct 22, 2009 |
Acorda Therapeutics Announces Extension of Fampridine-SR PDUFA Goal Date to January 22, 2010 |
| Oct 20, 2009 |
Zacks Analyst Blog Highlights: Biogen Idec Inc., Facet Biotech Corporation, Trubion Pharmaceuticals, Bristol-Myers Squibb and Acorda Therapeutics |
| Oct 19, 2009 |
Acorda Therapeutics Gets FDA Advisory Committee OK for Fampridine-SR |
| Oct 15, 2009 |
Blue Chips Continue Rally, but Nasdaq 100 Lags |
| Oct 15, 2009 |
Today's Pharmaceutical Big Gainers: Acorda Therapeutics, Solta Medical |
| Oct 15, 2009 |
Acorda Therapeutics (ACOR) NewsBite - ACOR Soars on FDA Panel Vote |
| Oct 15, 2009 |
ACOR: Shares Surge Following FDA Panel Recommendation to Approve MS Drug |
| |
| ZACKS COMMENTARY FOR ACOR |
| Nov 10, 2009 | Zacks Blog: Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics | | Nov 06, 2009 | Zacks Blog: Zacks Bull and Bear of the Day Highlights: Acorda Therapeutics, Canon, Big Lots, Wal-Mart and Nordstrom | | Nov 06, 2009 | Bull of the Day: Acorda Therapeutics (ACOR) | | Nov 03, 2009 | Zacks Equity Research: Report for ACOR | | Oct 20, 2009 | Zacks Blog: Biogen Reports Higher Earnings | | Oct 20, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Biogen Idec Inc., Facet Biotech Corporation, Trubion Pharmaceuticals, Bristol-Myers Squibb and Acorda Therapeutics | | Oct 19, 2009 | Zacks Blog: Biogen Extends Hostile Bid | | Oct 12, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Facet Biotech Corporation, Biogen Idec Inc., Trubion Pharmaceuticals, Bristol-Myers Squibb and Acorda Therapeutics | | Oct 09, 2009 | Zacks Blog: Facet Investors Urged to Deny Offer | | Sep 30, 2009 | Bull of the Day: Acorda Therapeutics (ACOR) | | Sep 23, 2009 | Zacks Blog: Biogen Launches Hostile Bid | | Sep 09, 2009 | Zacks Blog: Biogen Maintains Facet Offer |
|
|
Sponsored Links 
0.03